BiotechTube
Home/NG BIOTECH/Milovan Stankov Pugès
MS

Milovan Stankov Pugès

CEO

NG BIOTECH

Therapeutic Areas

Infectious DiseasesAntimicrobial ResistanceWomen's Health

NG BIOTECH Pipeline

DrugIndicationPhase
FDA-Designated AMR Test 1Detection of WHO-critical drug-resistant bacterial pathogenBreakthrough Device Designation
FDA-Designated AMR Test 2Detection of WHO-critical drug-resistant fungal/bacterial pathogenBreakthrough Device Designation
Carbapenemase Resistance DetectionAntimicrobial Resistance DetectionCommercial (CE Mark)
ESBL Resistance DetectionAntimicrobial Resistance DetectionCommercial (CE Mark)
Colistin Resistance DetectionAntimicrobial Resistance DetectionCommercial (CE Mark)
Candida auris DETECTIONFungal Infection DetectionCommercial (CE Mark)

Leadership Team at NG BIOTECH

MS
Milovan Stankov
Scientific Advisor
DA
Dr. Alain Calvo
Strategic Advisor
View full NG BIOTECH profile